| AASP | Aging-associated secretory phenotype |
| ALS | Amyotrophic lateral sclerosis |
| CCL-2 | C-C motif chemokine ligand 2 |
| Cdk/CdkI | Cyclin-dependent kinase/Cyclin-dependent kinase inhibitor |
| cGAS | Cyclic guanosine monophosphate – adenosine monophosphate synthase |
| CSF | Colony-stimulating factor |
| CXCL | Chemokine C-X-C motif ligand |
| DDR | DNA damage response |
| DNA-SCARS | DNA segments with chromatin alterations reinforcing senescence |
| DPP4 | Dipeptidyl peptidase-4 |
| FoxO | Forkhead box protein O |
| GH | Growth hormone |
| HLA | Human leukocyte antigen |
| HR | Homologous recombination |
| IGF-1 | Insulin-like growth factor-1 |
| iPSCs | Inducible pluripotent stem cells |
| LINE-1 | Long interspersed nuclear element-1 |
| LTR | Long terminal repeats |
| MAPK | Mitogen-activated protein kinase |
| MMP | Matrix-metalloprotease |
| mTOR | Mechanistic target of rapamycin |
| NF-κB | Nuclear factor κB |
| NK cell | Natural killer cell |
| OIS | Oncogene-induced senescence |
| PI3K | Phosphoinositid-3-kinase |
| PML | Promyelocytic leukemia protein |
| ROS | Reactive oxygen species |
| RS | Replicative senescence |
| SA-β-Gal | Senescence-associated-β-galactosidase |
| SAHF | Senescence-associated heterochromatic foci |
| SASP | Senescence associated secretory phenotype |
| SIPS | Stress-induced premature senescence |
| STH | Somatotropin |
| STING | Stimulator of interferon genes |
| TC-NER | Transcription-coupled nucleotide excision repair |